Media

Access a wide range of materials relating to our company, our people, innovation, solutions and diagnostics tools or get in touch with us.

In the spotlight

Mr. André Hoffmann and Dr. Jörg Duschmalé in conversation with Fortune India magazine!

Media Releases

Roche Launches Ocrevus® (Ocrelizumab) -a Breakthrough Blockbuster Therapy, Redefining Multiple Sclerosis (MS) Treatment in IndiaRoche launches Vabysmo® (faricimab), the first and only bispecific monoclonal antibody for the eye, to treat two leading causes of vision lossRoche unveils its first ever Customer Experience Center in ChennaiRoche and ZS partner to set up dedicated center in ChennaiRoche Pharma India Launches Patient Support App To Help Patients Seamlessly Navigate Their Care JourneyRoche expands its Global Analytics and Technology Center of ExcellenceFighting HER2 + Breast Cancer with innovation and hopeView all releases

Roche in the news

View allRoche's Evrysdi (Risdiplam) - the first and only oral treatment for adults and children two months or older suffering from Spinal Muscular Atrophy (SMA) now available in India.Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-IndiaRoche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19

Media Enquiries

For media enquiries, please contact:

©  Roche Products (India) Pvt. Ltd.  

Disclaimer: The images on this website are for representation purpose only and do not indicate actual patient outcomes or the effects of any product.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, visit us atOR please call the Roche India Safety Unit onor E-mail us at